CLOV Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
743.2M
-0.8%
749.2M
+53.6%
487.7M
-1.8%
496.6M
+4.0%
477.6M
Cost of Revenue
590.2M
+0.1%
589.6M
+42.6%
413.5M
-2.4%
423.5M
+12.0%
378.0M
Gross Profit
153.0M
-4.1%
159.5M
+115.0%
74.2M
+1.4%
73.2M
-26.5%
99.6M
Operating Expenses
125.0M
-5.5%
132.2M
+7.0%
123.5M
+26.6%
97.6M
-11.5%
110.2M
R&D
0
0
0
0
0
SG&A
124.4M
-5.5%
131.7M
+7.0%
123.1M
+26.7%
97.1M
-11.5%
109.8M
Operating Income
28.0M
+2.4%
27.3M
+155.4%
-49319000
-102.3%
-24377000
-130.9%
-10559000
EBITDA
28.1M
+2.7%
27.4M
+155.5%
-49400000
-95.2%
-25313000
-137.1%
-10674000
Net Income
28.0M
+2.4%
27.3M
+155.4%
-49320000
-102.3%
-24377000
-130.4%
-10578000
EPS (Basic)
$0.05
+0.0%
$0.05
+155.6%
$-0.09
-80.0%
$-0.05
-150.0%
$-0.02
EPS (Diluted)
$0.05
+0.0%
$0.05
+155.6%
$-0.09
-80.0%
$-0.05
-150.0%
$-0.02
Shares (Diluted)
545.4M
+2.4%
532.5M
+0.7%
529.0M
+3.2%
512.7M
+0.7%
509.0M
Clover Health Investments (CLOV) โ€” Financials